Amylin Plans Byetta sNDA Submission For Expanded Indication
The sNDA for use of exenatide in patients on thiazolidinediones will likely be submitted to FDA in mid-2006.
The sNDA for use of exenatide in patients on thiazolidinediones will likely be submitted to FDA in mid-2006.